Dr. Hanson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511- Is this information wrong?
Education & Training
- University of MinnesotaResidency, Pathology-Anatomic and Clinical, 1983 - 1987
- M Health FairviewInternship, Transitional Year, 1982 - 1983
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1982
Certifications & Licensure
- MN State Medical License 1993 - 2024
- NJ State Medical License 2004 - 2019
- MI State Medical License 1987 - 1994
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematology
Publications & Presentations
PubMed
- 3 citationsOne thousand patients with essential thrombocythemia: the Mayo Clinic experience.Karrar, O., Ketterling, R., Gangat, N., Al-Kali, A., Begna, K., Elliott, M., Wolanskyj-Spinner, A., Pardanani, A., Hanson, C., Tefferi, A.> ;Blood Cancer Journal. 2024 Jan 18
- 7 citationsA globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count.Ayalew Tefferi, Giuseppe G Loscocco, Faiqa Farrukh, Natasha Szuber, Francesco Mannelli, Animesh Pardanani, Curtis A Hanson, Rhett P Ketterling, Valerio De Stefano, Ale...> ;American Journal of Hematology. 2023 Dec 1
- Relationship among three common hematological premalignant conditions.Nicholas J Boddicker, Sameer A Parikh, Aaron D Norman, Kari G Rabe, Rosalie Griffin, Timothy G Call, Dennis P Robinson, Janet E Olson, Angela Dispenzieri, Vincent Rajk...> ;Leukemia. 2023 Aug 1
- Join now to see all
Abstracts/Posters
- Minimal Residual Disease (MRD) Assessment in the ECOG1411 Randomized Phase 2 Trial of Front-Line Bendamustine-Rituximab (BR)-Based Induction Followed By Rituximab (R) ...Curtis A. Hanson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell LymphocytosisCurtis A. Hanson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Ibrutinib and Rituximab Provides Superior Clinical Outcome Compared to FCR in Younger Patients with Chronic Lymphocytic Leukemia (CLL): Extended Follow-up from the E19...Curtis A. Hanson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- A Prospective Evaluation of Vitamin B1 (thiamine) Level in Myeloproliferative Neoplasms: Clinical Correlations and Impact of JAK2 Inhibitor Therapy2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Determinants of Long-Term Outcome in Type 1/like Calreticulin-Mutated Myelofibrosis2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- The Germline JAK2 GGCC (46/1) Haplotype and Survival Among 414 Molecularly-Annotated Patients with Primary Myelofibrosis2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Centralized Cardiac Monitoring Center Developed by Cleveland ClinicOctober 25th, 2017
- Primary Care Docs Spending About Half Their Work Days Interacting with EHRsOctober 13th, 2017
- Lab Rules Firing at the Time of Test Order; Possible on the LIS?October 9th, 2017
Hospital Affiliations
- Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: